About Conforma
Conforma is a Consumer company based in San Diego (United States) founded in 1999, and was acquired by Biogen in May 2006. Cancer drugs targeting HSP90 molecular chaperones are developed. Conforma has raised $56 million across 3 funding rounds from investors including Biogen, Lombard Odier and Domain Associates. Its chief executive, as recorded, is Lawrence Fritz. Its focus areas include Consumer Goods, Beauty & Personal Care Products, Appliances & Accessories and Contact Lenses. Its competitors include TrueLens, Black Pearl Vision and Art Optical Contact Lens; 1 of its 3 listed competitors has raised funding.
Company details
Conforma Therapeutics was founded in 1999 in San Diego, United States, and operates in the biotechnology sector. Focus is placed on the design and development of pharmaceutical products aimed at treating cancer. Operations center on drugs that target the HSP90 family of molecular chaperones, which regulate tumor cell growth and survival. The company is led by CEO and President Lawrence Fritz.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsConsumer
- Website conformacorp.com
- Social LinkedIn
- Acquired by Biogen (May 2006)
Funding Insights of Conforma
Conforma has successfully raised a total of $56M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $11 million completed in May 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $56M
- Total Rounds 3
- Last Round Series C — $11M
- First Round $15M
(May 2001)
- Investors Count 9
All 3 funding rounds of Conforma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2005 | $11M | Series C | – | – | |
| Sep 2003 | $30M | Series C | – | – | |
| May 2001 | $15M | Series A | – | – |
10 investors in total: 10 institutional.
Investors in Conforma
Conforma has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Biogen, Lombard Odier and Domain Associates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life science & tech focused VC firm investing in the US | domainvc.com | Princeton, United States | ||
Life Sciences focused VC firm that does early stage investments in the US | forwardventures.com | San Diego, United States | ||
Early-stage life sciences investments are targeted in the healthcare sector. | lillyventures.com | Indianapolis, United States | ||
| proquestvc.com | ||||
| rivervest.com | ||||
A biotechnology venture capital firm investing in innovative science. | srone.com | |||
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark | ||
| rbccm.com | ||||
Provider of wealth management services | 1796 | lombardodier.com | Geneva, Switzerland | |
Therapies for neurodegenerative and immunology disorders are developed. | 1978 | biogen.com | Cambridge, United States |
Investor details for Conforma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Conforma
1 people are tracked at Conforma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Lawrence Fritz | CEO & President | Leadership |
Complete people profiles for Conforma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Conforma
4 dated milestones of Conforma across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Conforma is founded.
- Funding First funding round of $15.0M.
- Funding Latest funding round, Series C, of $11.0M.
- Exit Acquired by Biogen.
Competitors of Conforma
Conforma has 3 listed competitors in our database, 1 of them funded. They include TrueLens, Black Pearl Vision and Art Optical Contact Lens.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| truelens.com | 2010 | Cambridge, United States | $1.2M | 928 | Social insights are integrated with CRM data for customer profiling. | |
| blackpearlvision.com | 2022 | Sarasota, United States | Contact lenses are branded and distributed by Black Pearl Vision. | |||
| artoptical.com | 1931 | Grand Rapids, United States | 49 | Specializes in designing, producing, and consulting on custom contact lenses for eye conditions. |
Detailed competitors of Conforma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Beauty & Personal Care Products
3 companies that operate in the same segment as Conforma (Beauty & Personal Care Products) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
3M is recognized as a global leader in industrial innovation. | 1902 | United States | USD 24.95 B | 74 | ||
Provider of FMCG conglomerate products | 1837 | United States | USD 457.23 M | 923 | ||
Subscription-based men's grooming products are provided by Harry's. | 2012 | New York, New York, United States | USD 755.88 M | 431 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Conforma
Conforma was founded in 1999 and raised its 1st funding round 2 years after it was founded.
Conforma is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Lawrence Fritz is the CEO of Conforma, as recorded in our data.
Conforma is a funded company, having raised a total of $56M across 3 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on May 2001.
Conforma Therapeutics was founded in 1999 in San Diego, United States, and operates in the biotechnology sector. Focus is placed on the design and development of pharmaceutical products aimed at treating cancer. Operations center on drugs that target the HSP90 family of molecular chaperones, which regulate tumor cell growth and survival. The company is led by CEO and President Lawrence Fritz.
Conforma's top competitors include TrueLens, Black Pearl Vision and Art Optical Contact Lens.
Conforma has 10 investors. Key investors include Biogen, Lombard Odier, Domain Associates, Forward Ventures, and Lilly Ventures.
Yes. Conforma was acquired by Biogen in May 2006.